
Among the researchers at the Cancer Center are three groups: basic scientists, translational researchers and clinical researchers. The basic scientists compare normal and abnormal cells, identifying and validating targets for drug intervention in vitro and in animal models. Translational researchers look for new investigational drugs and design human trials. The clinical researchers conduct Phase I, II and III trials with patients. These scientists and physician scientists work collaboratively.
Kapil Bhalla, MD, FACP Director, The MCG Cancer Center;
Developmental Therapeutics; Multidisciplinary Teams; Medical Oncologist

Developmental Therapeutics, Head and Neck Cancer Multidisciplinary Taskforce,
Thoracic Oncology Research Group, Pathologist

Molecular Oncology Program, Molecular Signaling; Institute of Molecular Medicine and Genetics
James A. Brown, MDMultidisciplinary Genitourinary / Prostate Cancer Team, Co-Director;
Surgeon, Urologic Oncologist
Darren Browning, PhDMolecular Oncology Program, Molecular Signaling
Anil G. Cashikar, PhDMolecular Oncology Program, Chaperone Biology
Center for Molecular Chaperones, Radiobiology and Cancer Virology
Ahmed Chadli, PhDMolecular Oncology Program, Chaperone Biology
Center for Molecular Chaperones, Radiobiology and Cancer Virology
John Cowell, PhD, DSc, FRCPath Associate Center Director for Basic Science;
Molecular Oncology Program, Molecular Signaling, Leader; Genomics / Epigenomics; Genetics Researcher
Quansheng Du, PhD, DScDevelopmental Therapeutics
